Skip to main content
Clinical Trials/NCT01812278
NCT01812278CompletedNot Applicable

Randomized Trial of Web-Delivered Acceptance Therapy for Smoking Cessation

Fred Hutchinson Cancer Center1 site in 1 country2,637 target enrollmentStarted: March 24, 2014Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
2,637
Locations
1
Primary Endpoint
30-day point prevalence abstinence

Study Overview

Brief Summary

The goal of this study is to determine whether the ACT website provides higher quit rates than a current standard smoking cessation website.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Investigator)

Eligibility Criteria

Ages
18 Years to 99 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •age 18 or older
  • •smokes at least five cigarettes daily for at least past 12 months
  • •wants to quit in next 30 days
  • •willing to be randomly assigned to either group
  • •resides in US
  • •has at least weekly access to a high speed Internet connection and email
  • •willing and able to read in English
  • •not participating in other smoking cessation interventions (including our other intervention studies
  • •has never used the Smokefree.gov website
  • •willing to complete all three follow-up surveys
  • •provide email, phone, and mailing address
  • •provide contact information for two collaterals (e.g., relatives).
  • •does not have family, friends, or other household members participating

Exclusion Criteria

  • •The exclusion criteria are the opposite of the inclusion criteria above.

Arms & Interventions

ACT

Experimental

Acceptance & Commitment Therapy

Intervention: ACT (Behavioral)

CBT

Active Comparator

Cognitive Behavioral Therapy

Intervention: CBT (Behavioral)

Outcomes

Primary Outcomes

30-day point prevalence abstinence

Time Frame: 12 month post randomization

No smoking in the past 30 days, as reported 12 month post treatment.

Secondary Outcomes

  • 7-day, 24-hour, and 30-day point prevalence quit rates(3 months, 6 months, and 12 months post treatment)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials